Carcinoma: all 6,719 studies

Page 12 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.

• A Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsRecruitingNCT03475953Phase 1/2
• SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
• Determination of Autonomic Responses to the Exposure of Low Energy Electromagnetic Fields With Frequency Modulation in Patients With Advanced Hepatocellular Carcinoma and Healthy Individuals.RecruitingNCT03448757Not applicable
• A Study of PTS100 in Primary HCC PatientsRecruitingNCT03447951Phase 2
• Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell CarcinomaRecruitingNCT03414827
• Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell CarcinomaRecruitingNCT03406247Phase 2
• Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCCRecruitingNCT03370406Phase 1
• Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal CancerNot yet recruitingNCT03367884Not applicable
• XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring CarcinomaNot yet recruitingNCT03355612Phase 3
• Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma PatientsRecruitingNCT03353467Not applicable
• Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without NephroureterectomyNot yet recruitingNCT03345134Phase 2
• Renal Adjuvant MultiPle Arm Randomised TrialRecruitingNCT03288532Phase 3
• Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer PatientsRecruitingNCT03280511Phase 2
• GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 ExpressionRecruitingNCT03198546Phase 1
• A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid TumorsRecruitingNCT03129139Phase 1
• A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 RearrangementsRecruitingNCT03093116Phase 1/2
• Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal CarcinomatosisRecruitingNCT03073694Phase 2
• Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck CancerRecruitingNCT03010150
• Accelerated Modulated Fractionation (SIB-IMRT) for Head and Neck DistrictRecruitingNCT03001570Phase 2
• Development of Diagnostics and Treatment of Urological CancersRecruitingNCT02994758Not applicable
• Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)TherapyNot yet recruitingNCT02990936
• Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial CarcinomaRecruitingNCT02969083Phase 2
• Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate CancerRecruitingNCT02935205Phase 1/2
• Proteomics of Papillary Thyroid CarcinomaRecruitingNCT02814032
• Laparoscopic Surgery VS RFA for Recurrent HCCNot yet recruitingNCT02785380Phase 4
• Oral Vitamin D Treatment for the Prevention of Hepatocellular CarcinomaNot yet recruitingNCT02779465Phase 4
• Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryRecruitingNCT02734537Phase 2
• Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal CarcinomaRecruitingNCT02610010Phase 3
• CIK in Treating Patients With Esophageal CancerNot yet recruitingNCT02490735Phase 2
• MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular CarcinomaNot yet recruitingNCT02448056
• Intra-operative Radiotherapy For Women With Ductal Carcinoma in Situ Breast CancerRecruitingNCT02389673Not applicable
• Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 StageRecruitingNCT02290145Phase 2
• GDF15 Based TPF Induction Chemotherapy for OSCC PatientsRecruitingNCT02285530Phase 2
• Collection of Plasma Samples for Squamous Cell Carcinoma of the Head and Neck PatientsRecruitingNCT02139020
• Peritoneal Surface Malignancies - Characterization, Models and Treatment StrategiesRecruitingNCT02073500
• Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal VaricesRecruitingNCT01970748Phase 4
• A Phase II Study of Cyberknife Radiosurgery for Renal Cell CarcinomaRecruitingNCT01890590Not applicable
• An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)Enrolling by invitationNCT01511393
• Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch StudiesEnrolling by invitationNCT00923026
• Novel Serum Markers for Monitoring Response to Anti-Cancer TherapyRecruitingNCT00349830
• Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior ChemotherapyRecruitingNCT00100256Phase 1/2
• Collection of Blood and Urine From Patients Undergoing Radiation TherapyEnrolling by invitationNCT00027326
• SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAACompletedNCT05848947Phase 4Results posted
• Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCCTerminatedNCT05776875Phase 2Results posted
• A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.CompletedNCT05745142Results posted
• A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular CarcinomaTerminatedNCT05653427Phase 2Results posted
• Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2)CompletedNCT05650164Results posted
• A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical CarcinomaTerminatedNCT05634577Phase 2Results posted
• Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic TherapyTerminatedNCT05630937Phase 1/2Results posted
• Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study).TerminatedNCT05534789Results posted
• Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell CarcinomaTerminatedNCT05461794Phase 2Results posted
• A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has SpreadCompletedNCT05431777Results posted
• A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.CompletedNCT05363072Results posted
• Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian CancerTerminatedNCT05261490Phase 1/2Results posted
• Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular CarcinomaTerminatedNCT05249569Phase 2Results posted
• TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.CompletedNCT05233098Results posted
• A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx CancerActive, not recruitingNCT05232851Phase 1/2Results posted
• Open-Label Proof of Concept Study of VP-315 in Basal Cell CarcinomaCompletedNCT05188729Phase 2Results posted
• Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPCTerminatedNCT05166577Phase 1Results posted
• Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.CompletedNCT05110196Phase 4Results posted
• EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast CancerCompletedNCT05086705Not applicableResults posted
• Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard TherapiesCompletedNCT05054725Phase 2Results posted
• Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast CancerTerminatedNCT05041101Phase 1/2Results posted
• T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial CancersTerminatedNCT05035407Phase 1Results posted
• Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic CancerCompletedNCT05014776Phase 2Results posted
• Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)CompletedNCT05012865Results posted
• Milademetan in Advanced/Metastatic Solid TumorsTerminatedNCT05012397Phase 2Results posted
• Incidence of Melanoma and Non-melanoma Skin Cancer in People With VitiligoCompletedNCT04969419Results posted
• A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri MetsCompletedNCT04950166Phase 2Results posted
• A Study Investigating the Efficacy and Safety of Ociperlimab and Tislelizumab and BAT1706 Combinations in Patients With Advanced HCCCompletedNCT04948697Phase 2Results posted
• Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One FractionCompletedNCT04939246Not applicableResults posted
• Addressing Cancer-Related Financial Toxicity in North Carolina Oncology Care SettingsCompletedNCT04931251Not applicableResults posted
• 11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor ExpressionTerminatedNCT04927663Phase 1Results posted
• Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate CancerTerminatedNCT04926181Phase 2Results posted
• Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLCTerminatedNCT04925986Phase 2Results posted
• A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint InhibitorsTerminatedNCT04925947Phase 2Results posted
• IFx-Hu2.0 for the Treatment of Patients With Skin CancerCompletedNCT04925713Phase 1Results posted
• CellFX Treat & Resect Low-Risk BCC Feasibility StudyCompletedNCT04918381Not applicableResults posted
• Clinical Outcomes for Offering Genetic Testing in a Tiered ApproachCompletedNCT04902144Not applicableResults posted
• Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVICompletedNCT04891874Not applicableResults posted
• Neoadjuvant Imiquimod Immunotherapy for Oral CancerCompletedNCT04883645Early Phase 1Results posted
• RegoNivo vs Standard of Care Chemotherapy in AGOCCompletedNCT04879368Phase 3Results posted
• Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)TerminatedNCT04871529Phase 2Results posted
• Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.TerminatedNCT04812535Phase 2Results posted
• Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell CarcinomaTerminatedNCT04807777Phase 2Results posted
• Survey of Cabozantinib Used To Treat People With Renal Cell CarcinomaCompletedNCT04804813Results posted
• Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT04753216Phase 2Results posted
• Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast CancerCompletedNCT04750473Phase 1Results posted
• A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCPCompletedNCT04740164Not applicableResults posted
• Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell CarcinomaCompletedNCT04732494Phase 2Results posted
• A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic TherapyTerminatedNCT04732286Phase 3Results posted
• Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell CarcinomaCompletedNCT04710498Phase 2Results posted
• Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint InhibitorsCompletedNCT04696055Phase 2Results posted
• A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder CancerTerminatedNCT04688931Phase 3Results posted
• Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CTTerminatedNCT04685798Not applicableResults posted
• Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive DiseaseTerminatedNCT04685499Phase 2Results posted
• To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell CarcinomaCompletedNCT04682587Results posted
• Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell CarcinomaCompletedNCT04649476Phase 2Results posted
• Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung CancerTerminatedNCT04639245Phase 1/2Results posted
• Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck CancerTerminatedNCT04634825Phase 2Results posted

← Carcinoma overview